3-196323912-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6_Moderate
The NM_138461.4(TM4SF19):c.535G>A(p.Ala179Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000335 in 1,613,910 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_138461.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TM4SF19 | NM_138461.4 | c.535G>A | p.Ala179Thr | missense_variant | 5/5 | ENST00000273695.4 | NP_612470.2 | |
TM4SF19-DYNLT2B | NR_037950.1 | n.693G>A | non_coding_transcript_exon_variant | 5/6 | ||||
TM4SF19-AS1 | NR_046724.1 | n.189C>T | non_coding_transcript_exon_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TM4SF19 | ENST00000273695.4 | c.535G>A | p.Ala179Thr | missense_variant | 5/5 | 1 | NM_138461.4 | ENSP00000273695 | P1 | |
TM4SF19-AS1 | ENST00000452051.1 | n.171C>T | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152034Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000517 AC: 13AN: 251216Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135802
GnomAD4 exome AF: 0.0000315 AC: 46AN: 1461876Hom.: 0 Cov.: 30 AF XY: 0.0000358 AC XY: 26AN XY: 727234
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152034Hom.: 0 Cov.: 32 AF XY: 0.0000808 AC XY: 6AN XY: 74248
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at